Coherus Biosciences Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $3.70 on 01/02/24, while the lowest value for the same period was recorded at $0.66 on 11/05/24.
52-week price history of CHRS Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Coherus Biosciences Inc’s current trading price is -79.12% away from its 52-week high, while its distance from the 52-week low is 17.01%. The stock’s price range during this period has spanned from $0.66 to $3.70. In the Healthcare sector, the Coherus Biosciences Inc’s shares surpassed a trading volume of approximately 2.43 million for the day, which was noticeably lower compared to the average daily volume of 9.2.54 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Coherus Biosciences Inc (CHRS) has experienced a quarterly decline of -38.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 89.02M and boasts a workforce of 306 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2124, with a change in price of -0.8074. Similarly, Coherus Biosciences Inc recorded 2,291,096 in trading volume during the last 100 days, posting a change of -51.10%.
CHRS Stock Stochastic Average
Today, Coherus Biosciences Inc’s raw stochastic average for the past 50 days stands at 15.82%, indicating a decline from the raw stochastic average of the last 20 days, which was 38.11%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 44.55% and 45.21% respectively.
CHRS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -76.80% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -64.40%. Over the past 30 days, the price of CHRS has leaped by -12.86%. And in the last five days, it has fallen by -5.78%.
